Description
Research Peptide
Contents Per Vial
- IGF-1 LR3 — 1 mg
Total Peptide Content: 1 mg
Form: Sterile Lyophilized Powder
Purity: ≥99% (HPLC-Tested Batches)
Storage: Store at −20°C away from direct light
Packaging: Laboratory glass vial with protective sleeve
Product Overview
IGF-1 LR3™ is a long-acting analog of insulin-like growth factor-1 (IGF-1) developed for investigational and laboratory research applications involving cellular growth signaling, protein synthesis pathways, metabolic activity, and tissue development mechanisms.
Due to structural modifications that extend its biological activity, IGF-1 LR3 has been widely utilized in preclinical research examining cellular proliferation, nutrient partitioning, anabolic signaling pathways, and interactions with growth factor receptors.
Researchers frequently employ IGF-1 LR3 in studies investigating mechanisms associated with skeletal muscle biology, tissue regeneration, metabolic regulation, and growth factor-mediated cellular responses.
This product is supplied exclusively for laboratory research and analytical purposes.
Intended Research Applications
This formulation may be utilized in controlled laboratory environments for investigation into:
- Cellular growth and proliferation pathways
- Growth factor receptor signaling
- Protein synthesis mechanisms
- Skeletal muscle biology research
- Metabolic regulation studies
- Nutrient utilization pathways
- Tissue regeneration and repair mechanisms
- Cell differentiation and development research
Important Notice
FOR RESEARCH USE ONLY.
This material is not intended for human consumption, veterinary use, therapeutic application, or diagnostic purposes.
Products sold by Lonestar Labs are intended solely for qualified researchers and licensed laboratory professionals operating in compliance with applicable laws and regulations.
These statements have not been evaluated by the U.S. Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
